- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04580511
Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction (PMCF_AWR)
Safety and Clinical Performance of a Non-cross-linked Porcine Acellular Dermal Matrix Used in Abdominal Wall Reconstruction: an Observational Prospective Study.
The general objective of the study is to confirm the medium/long-term safety and clinical performance of the CELLIS membrane used in abdominal wall reconstruction including, but not limited to, ventral hernia repair and stoma closure, and to identify emerging risks in comparison to the clinical data related to other types of fixation material.
The present study will be a prospective multicentric non-randomized and noncontrolled trial involving 112 patients followed for 24 months. The study will be conducted in France in 3 investigational centres.
Study Overview
Status
Intervention / Treatment
Detailed Description
The study will be prospective, multicentric, single-arm, observational (non-interventional) to evaluate the safety and performance of the CELLIS membrane used in abdominal wall reconstruction including, but not limited to, ventral hernia repair and stoma closure.
All evaluations will be performed and products used according to the usual practice, without additional or unusual diagnostic, treatment and monitoring procedure.
The study will be conducted in France in 3 investigational centres including 112 patients scheduled for an abdominal wall reconstruction.
Each patient will participate in one assessment period including a preoperative visit, followed by the day of surgical procedure and a hospitalization period.
Patients will return for ambulatory visits on day 30 (+/- 7 days), on month 3 (+/- 2 weeks), on month 12 (+/- 2 weeks) and on month 24 (+/-2 weeks) post-surgery.
CELLIS will be implanted by open technique following standard techniques. The membrane can be used in bridged or reinforced repairs. Mesh placement can include inlay (bridging), underlay intraperitoneal, sublay (retrorectus/retromuscular) positions.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Guillaume HOFMANSKI
- Phone Number: +33 (0)7 61 31 11 33
- Email: guillaume.hofmanski@meccellis.com
Study Contact Backup
- Name: Claire CISTERNI, PhD
- Phone Number: +33 (0)6 68 13 76 26
- Email: claire.cisterni@meccellis.com
Study Locations
-
-
-
Caen, France
- Recruiting
- CHU Caen Normandie, Service de Chirurgie Digestive
-
Contact:
- Gil LEBRETON, MD
-
Principal Investigator:
- Gil Lebreton, MD
-
La Rochelle, France
- Recruiting
- Groupe Hospitalier La Rochelle - Re - Aunis
-
Contact:
- Hélène GIBELIN, MD
-
Principal Investigator:
- Hélène GIBELIN, MD
-
Montpellier, France
- Recruiting
- CHU Montpellier, Hôpital Saint-Eloi, Pôle digestif, Service de Chirurgie Digestive B et Transplantation
-
Contact:
- Hassan BOUYABRINE, MD
-
Principal Investigator:
- Hassan BOUYABRINE, MD
-
Nantes, France, 44093
- Recruiting
- CHU Nantes Hôtel Dieu
-
Contact:
- Claire BLANCHARD-LOUIS, MD
-
Principal Investigator:
- Claire BLANCHARD-LOUIS, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient aged ≥18 years,
- Patient with an indication of abdominal wall reconstruction including, but not limited to, ventral hernia repair and stoma closure,
- Patient being informed of its participation to the study and of the follow-up visits, and having no objection to the clinical data collection and medical file access,
- Patient being informed of the porcine origin of the device in advance of the procedure.
Exclusion Criteria:
- Patient with known hypersensitivity to porcine materials,
- Patient who is pregnant,
- Patient having refused to participate to the study,
- Patient refusing to return for the follow-up visits.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of adverse events including reoperation and removal of the mesh. The main complications of interest are Surgical Site Occurrence (SSO) including Surgical Site Infection (SSI).
Time Frame: From the surgical procedure throughout the entire 24-month follow-up period
|
Percentage
|
From the surgical procedure throughout the entire 24-month follow-up period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of recurrence/incisional hernia evaluated by clinical examination and/or CT-scan
Time Frame: Throughout the study until end of the 24-month follow-up period
|
Percentage
|
Throughout the study until end of the 24-month follow-up period
|
Rate of recurrence/incisional hernia requiring reoperation
Time Frame: Throughout the study until end of the 24-month follow-up period
|
Percentage
|
Throughout the study until end of the 24-month follow-up period
|
Rate of abdominal wall laxity
Time Frame: Throughout the study until end of the 24-month follow-up period
|
Percentage
|
Throughout the study until end of the 24-month follow-up period
|
Description of device deficiency: inadequacy of a medical device with respect to its identity, quality, durability, reliability, safety or performance. Device deficiencies include malfunctions, use errors, and inadequate labelling.
Time Frame: During the surgical procedure
|
Summarized and listed
|
During the surgical procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hassan BOUYABRINE, MD, CHU Montpellier, France
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AWR_01_CIP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Hernia
-
Spital Limmattal SchlierenCompleted
-
Aesculap AGB.Braun Surgical SACompletedVentral Hernia | Abdominal Hernia | Abdominal Wall Defect | Fascial HerniaSpain
-
Musculoskeletal Transplant FoundationWashington University School of Medicine; Pines Surgical; Meridian Healthcare...CompletedHernia of Abdominal WallUnited States
-
Joanne TurnerNot yet recruitingAbdominal Surgery | Abdominal Hernia
-
AbbVieNot yet recruiting
-
Washington University School of MedicineCompletedHernia, VentralUnited States
-
University of Lausanne HospitalsCompletedPostoperative Complications | HerniaSwitzerland
-
Henares University HospitalCompletedHernia | Abdominal Wall Defect | Incisional Hernia | Abdominal Wall HerniaSpain
-
Assiut UniversityNot yet recruitingAbdominal Hernia
-
NorthShore University HealthSystemMedtronicRecruiting
Clinical Trials on CELLIS (Porcine Acellular Dermal Matrix, PADM)
-
Meccellis BiotechRecruitingBreast Reconstruction Following MastectomyFrance
-
Meccellis BiotechRecruitingDental SurgeryFrance
-
Meccellis BiotechCompleted
-
Musculoskeletal Transplant FoundationWashington University School of Medicine; Pines Surgical; Meridian Healthcare...CompletedHernia of Abdominal WallUnited States
-
University of Campinas, BrazilRecruiting
-
Istituto Ortopedico RizzoliRecruiting
-
Aarhus University HospitalCompletedSurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized TrialBreast NeoplasmsDenmark
-
Faculty of Dental Medicine for GirlsCompletedComparative StudyEgypt
-
West China HospitalCompleted